corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 19949

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Magazine

Burge K
Data sales risk patient trust
Medical Observer 2004 Nov 129
http://www.rheumatologyupdate.com.au/news/data-sales-risk-patient-trust---mo-news


Full text:

A health law expert has warned GPs against selling de-identified patient data, saying the risk to the patient-doctor relationship could outweigh any financial gains.

Phillips Fox health law partner Dr Tim Smyth said while he could understand the commercial interest in GP prescribing information, “my gut feeling is that it’s not worth getting involved in”.

“Patients might lose trust in their doctors on this issue and might wonder whether the doctor’s prescribing is being influenced by payments being received. So I think doctors need to consider whether they seriously want to get involved in that.”

The warning follows claims by the Australian Consumer Association (ACA) that doctors were being offered “bribes” for data, after a leaked fax revealed that a company called Camm Pacific was offering GPs a payment or gift voucher in exchange for de-identified electronic patient information.

In the fax, the company claims “de-identified prescription data” would be used for pharmaceutical research conducted online using a Medical Director software program.

ACA senior health policy officer Nicola Ballenden said this broke the trust of the doctor-patient relationship and could be in breach of the National Privacy Principles.

Deputy Federal Privacy Commissioner Timothy Pilgrim said the office intends to conduct an investigation to establish whether or not the proposed activity would be a breach of the Privacy Act.

The incident comes months after it was revealed in Medical Observer (March 5) that at least one software company asked GPs to sign over their intellectual property rights to their medical records when signing renewal contracts.

The latest allegations have prompted a warning from General Practice Computing Group (GPCG) chair Dr Ron Tomlins, for GPs to be aware of their obligations to protect confidential patient information.

“All consumers have the right to have their personal medical information kept private and secure,” Dr Tomlins said.

Dr Smyth said the privacy legislation didn’t apply to information that does not identify or could not reasonably identify a person but the situation raised ethical questions, such as the degree of control patients should have over their data even if it is de-identified.

If you are going to enter into any agreement Phillips Fox suggests these are some things you need to consider.

The agreement should only be for a certain time-period The doctor must be able to terminate the deal at any time, especially if there is any breach of those conditions about privacy and confidentiality Doctors should ensure the use of the de-identified data cannot adversely affect he doctor or the practice.~MO

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Cases of wilful misrepresentation are a rarity in medical advertising. For every advertisement in which nonexistent doctors are called on to testify or deliberately irrelevant references are bunched up in [fine print], you will find a hundred or more whose greatest offenses are unquestioning enthusiasm and the skill to communicate it.

The best defence the physician can muster against this kind of advertising is a healthy skepticism and a willingness, not always apparent in the past, to do his homework. He must cultivate a flair for spotting the logical loophole, the invalid clinical trial, the unreliable or meaningless testimonial, the unneeded improvement and the unlikely claim. Above all, he must develop greater resistance to the lure of the fashionable and the new.
- Pierre R. Garai (advertising executive) 1963